GSK has received approval for its vaccine, AREXVY, in Canada to prevent LRTD caused by RSV in adults aged 50 to 59 years.

Britons across the nation are experiencing what they're calling 'the worst cold ever', as this winter's illnesses strike hard ...

Among physicians in Washington state, high prescribers of opioids were 2.9 times more likely to be high prescribers of ...

This update in the health sector highlights major developments including DiaSorin's significant profit growth, GSK's RSV ...

Dr. Kerry-Anne Perkins, a new mom and board-certified OB-GYN shares what parents need to know about RSV and more.

About 2.1% of antibiotic prescriptions over the study period were connected to RSV diagnoses, especially in seniors and ...

Vermont has the second lowest state fatality rate in the US (141.1 per 100K; Hawaii 111.7/100K). Mississippi (457.4/100K) and ...

Doctors say they are seeing an unusual spike in walking pneumonia cases in parts of Canada, particularly in kids, but their ...

Respiratory illnesses like the flu and COVID-19 spread more commonly in the fall and winter months ahead, and doctors in ...

Each year, up to 160,000 older adults living in the United States are hospitalized and as many as 10,000 die due to respiratory syncytial virus (RS ...

But in 2022, after the pandemic precautions relaxed, cases of influenza and RSV surged. Now it appears whooping cough is back as well: This week, the Washington State Department of Health reported ...

GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...